ACTIVE SUBSTANCE / INN

GABAPENTIN

Brand name(s): GABAPENTIN, NEURONTIN, GRALISE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA021129
NDA022544
ACTIVE SUBSTANCE
Gabapentin
REGULATORS
FDA
SPONSORS / MAH
IVAX SUB TEVA PHARMS, VIATRIS, STRIDES PHARMA
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
GABAPENTINANDA206943STRIDES PHARMAPrescription
GABAPENTINANDA076017IVAX SUB TEVA PHARMSDiscontinued
NEURONTINNDA021129VIATRISPrescription
GABAPENTINANDA203611ACTAVIS ELIZABETHNone (Tentative Approval)
GRALISENDA022544ALMATICAPrescription

FULL INTELLIGENCE ON GABAPENTIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →